Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. 

Biotechnology

Cara Therapeutics

Christopher Posner

Jo Goncalves

Ryan Maynard

Iris Francesconi

Beth Weinberg

Scott Terrillion

Eric Vandal

Frédérique Menzaghi

The executive team at Cara Therapeutics has experience in the medical field, specifically in dermatology and neurology. They have also worked in brand safety and scientific affairs. The team is educated, with a member having a degree in medicine from the University of Cape Town.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Cara Therapeutics

Leadership Team

Board of Directors